This is the authors' abstract. We don't add key points for this paper.
The use of macrolides against pneumonia has been reported to improve survival; however, little is known about their efficacy against methicillin-resistant Staphylococcus aureus (MRSA) pneumonia. In this study, we investigated the effect of azithromycin (AZM) and compared it with that of vancomycin (VCM) and daptomycin (DAP) in a murine model of MRSA pneumonia. Mice were infected with MRSA by intratracheal injection and then treated with AZM, VCM, or DAP.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Yamashita et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: